Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
This study has been completed.
Study NCT00043849   Information provided by National Institute on Aging (NIA)
First Received: August 14, 2002   Last Updated: August 22, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dementia
Parkinson Disease
Additional conditions recognized in this trial
Parkinsonian Disorders
Psychotic Disorders
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Quetiapine
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute on Aging (NIA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services